Literature DB >> 8002207

Changes in urinary kallikrein excretion and plasma natriuretic factor in a patient with primary aldosteronism with special reference to adrenal histology.

S Hayami1, T Nakada, H Kakizaki, T Yagisawa, H Kaneko, Y Iijima, H Obata, M Miura.   

Abstract

High level of urinary kallikrein excretion was observed in a 23-year-old man with primary aldosteronism. Unilateral adrenalectomy improved the clinical symptoms and normalized the urinary concentration of this vasoactive substance. Although plasma atrial natriuretic factor was not elevated, adrenal surgery lowered its concentration. Coexistence of an adrenal adenoma and lesions of nodular hyperplasia were detected in the removed adrenal gland. We summarize the clinical data of this patient and review the literature.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8002207     DOI: 10.1007/BF02768004

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

1.  The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism.

Authors:  T Nakada; H Furuta; T Katayama; H Sumiya; J Shimazaki
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

2.  Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.

Authors:  H S Margolius; D Horwitz; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

Review 3.  The nodular adrenal.

Authors:  A M Neville
Journal:  Invest Cell Pathol       Date:  1978 Jan-Mar

4.  The effect of cations on the activity of human urinary kallikrein.

Authors:  W Lieberthal; N B Oza; D B Bernard; N G Levinsky
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

5.  Abnormal urinary kallikrein in hypertension is not related to aldosterone or plasma renin activity.

Authors:  W J Lawton; A E Fitz
Journal:  Hypertension       Date:  1980 Nov-Dec       Impact factor: 10.190

6.  Urinary kallikrein excretion in essential and mineralocorticoid hypertension.

Authors:  O B Holland; J M Chud; H Braunstein
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

7.  Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma.

Authors:  Y Ito; Y Fujimoto; T Obara; T Kodama
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

8.  Low dose atrial natriuretic factor in primary aldosteronism: renal, hemodynamic, and vascular effects.

Authors:  R Pedrinelli; G Panarace; M Spessot; S Taddei; S Favilla; L Graziadei; A Lucarini; A Salvetti
Journal:  Hypertension       Date:  1989-08       Impact factor: 10.190

9.  Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man.

Authors:  F Sato; K Kamoi; Y Wakiya; T Ozawa; O Arai; M Ishibashi; T Yamaji
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

10.  Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension.

Authors:  T Yamaji; M Ishibashi; H Sekihara; F Takaku; H Nakaoka; J Fujii
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.